VThunter
a database for single-cell screening of virus target cells in animal kingdom
Dog

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis; Canis lupus,

Latin Name: Canis lupus familiaris

Tested tissues: Lung, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0048 2021.04 10X Genomics Lung Normal 4040 Link
Vthunter_100004 2021.05 10X Genomics PBMC Normal 6868 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Dengue virus
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
PBMC-Macrophage : 54.69% ;
PBMC-DCs : 22.52% ;
Lung-Macrophages : 23.53% ;
Sindbis virus
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Adeno-associated virus 9
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Classical swine fever virus
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Adeno-associated virus - 2
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Endothelial cells : 83.70% ;
Lung-ATII : 41.52% ;
Lung-Ciliated cells : 34.28% ;
Lung-Macrophages : 29.41% ;
Lung-Fibroblasts : 22.36% ;
Lung-Ciliated cells : 54.56% ;
Lung-Secretory cells : 50.17% ;
Lung-ATII : 38.35% ;
Lung-Fibroblasts : 36.99% ;
Lung-ATI : 31.40% ;
Adeno-associated virus - 8
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Adeno-associated virus - 3
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Venezuelan equine encephalitis virus
PBMC-Macrophage : 100.00% ;
PBMC-B cells : 99.77% ;
PBMC-Monocytes : 99.72% ;
PBMC-NK cells : 99.69% ;
PBMC-DCs : 90.88% ;
Vesicular stomatitis virus
Lung-Ciliated cells : 96.70% ;
Lung-Secretory cells : 92.33% ;
Lung-ATI : 86.80% ;
Lung-Fibroblasts : 82.93% ;
Lung-ATII : 81.22% ;
Lung-Ciliated cells : 52.85% ;
Lung-Secretory cells : 47.74% ;
Lung-ATII : 46.27% ;
Lung-ATI : 26.80% ;
Lung-Fibroblasts : 21.54% ;
Influenza A virus
Lung-Ciliated cells : 96.70% ;
Lung-Secretory cells : 92.33% ;
Lung-ATI : 86.80% ;
Lung-Fibroblasts : 82.93% ;
Lung-ATII : 81.22% ;
Lung-Fibroblasts : 76.02% ;
Lung-Ciliated cells : 32.46% ;
Lung-Endothelial cells : 25.00% ;
Lung-ATII : 22.62% ;
PBMC-Macrophage : 64.06% ;
Lung-Ciliated cells : 36.90% ;
Lung-Fibroblasts : 32.11% ;
PBMC-DCs : 24.76% ;
Lung-ATI : 21.40% ;
Lung-Secretory cells : 63.07% ;
Lung-Ciliated cells : 40.20% ;
Lung-Fibroblasts : 35.37% ;
Lung-ATII : 29.64% ;
Coxsackievirus A16
PBMC-DCs : 92.61% ;
PBMC-T cells : 50.39% ;
PBMC-Macrophage : 43.75% ;
Lung-Ciliated cells : 39.07% ;
Lung-ATII : 33.26% ;
Enterovirus A71
PBMC-DCs : 92.61% ;
PBMC-T cells : 50.39% ;
PBMC-Macrophage : 43.75% ;
Lung-Ciliated cells : 39.07% ;
Lung-ATII : 33.26% ;
PBMC-Macrophage : 81.25% ;
PBMC-B cells : 38.58% ;
PBMC-Monocytes : 37.02% ;
PBMC-NK cells : 27.91% ;
PBMC-DCs : 27.10% ;
Human mastadenovirus B
PBMC-Macrophage : 90.62% ;
PBMC-DCs : 37.39% ;
Lung-Macrophages : 27.45% ;
PBMC-NK cells : 25.77% ;
Rhinovirus C
Lung-Ciliated cells : 90.43% ;
Simian rotavirus A strain RRV
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Ciliated cells : 82.80% ;
Lung-Fibroblasts : 69.51% ;
Lung-Secretory cells : 62.37% ;
Lung-ATII : 46.04% ;
Lung-Endothelial cells : 36.96% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
Lung-ATII : 31.33% ;
Lung-Secretory cells : 26.48% ;
Lung-Ciliated cells : 23.46% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Human betaherpesvirus 5
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Secretory cells : 63.07% ;
Lung-Ciliated cells : 40.20% ;
Lung-Fibroblasts : 35.37% ;
Lung-ATII : 29.64% ;
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Human gammaherpesvirus 4
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Human parvovirus B19
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Endothelial cells : 83.70% ;
Lung-ATII : 41.52% ;
Lung-Ciliated cells : 34.28% ;
Lung-Macrophages : 29.41% ;
Lung-Fibroblasts : 22.36% ;
Equid alphaherpesvirus 1
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
PBMC-Macrophage : 62.50% ;
PBMC-B cells : 54.34% ;
PBMC-NK cells : 47.24% ;
PBMC-Monocytes : 38.95% ;
PBMC-DCs : 21.96% ;
Mammalian orthoreovirus
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Ciliated cells : 82.80% ;
Lung-Fibroblasts : 69.51% ;
Lung-Secretory cells : 62.37% ;
Lung-ATII : 46.04% ;
Lung-Endothelial cells : 36.96% ;
Human metapneumovirus
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Endothelial cells : 83.70% ;
Lung-ATII : 41.52% ;
Lung-Ciliated cells : 34.28% ;
Lung-Macrophages : 29.41% ;
Lung-Fibroblasts : 22.36% ;
Echovirus E8
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-ATII : 31.33% ;
Lung-Secretory cells : 26.48% ;
Lung-Ciliated cells : 23.46% ;
Foot-and-mouth disease virus
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Ciliated cells : 85.31% ;
Lung-ATII : 80.66% ;
Lung-Secretory cells : 77.00% ;
Lung-ATI : 69.60% ;
Lung-Fibroblasts : 46.34% ;
Lung-Endothelial cells : 83.70% ;
Lung-ATII : 41.52% ;
Lung-Ciliated cells : 34.28% ;
Lung-Macrophages : 29.41% ;
Lung-Fibroblasts : 22.36% ;
Lung-Ciliated cells : 81.89% ;
Lung-Fibroblasts : 62.60% ;
Lung-Secretory cells : 41.12% ;
Lung-ATII : 33.37% ;
Lung-ATI : 23.60% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Echovirus E1
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-ATII : 31.33% ;
Lung-Secretory cells : 26.48% ;
Lung-Ciliated cells : 23.46% ;
Human rotavirus strain WA
PBMC-Macrophage : 87.50% ;
PBMC-NK cells : 68.10% ;
PBMC-Platelets : 67.29% ;
PBMC-DCs : 50.08% ;
Lung-Fibroblasts : 45.12% ;
Lung-Ciliated cells : 82.80% ;
Lung-Fibroblasts : 69.51% ;
Lung-Secretory cells : 62.37% ;
Lung-ATII : 46.04% ;
Lung-Endothelial cells : 36.96% ;
Lung-ATII : 31.33% ;
Lung-Secretory cells : 26.48% ;
Lung-Ciliated cells : 23.46% ;
Human mastadenovirus D
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Coxsackievirus B3
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Coxsackievirus B2
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Human mastadenovirus A
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Human mastadenovirus C
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Lung-Ciliated cells : 78.93% ;
Lung-Secretory cells : 67.25% ;
Lung-Fibroblasts : 64.63% ;
Lung-ATI : 36.20% ;
Lung-Endothelial cells : 32.61% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
Coxsackievirus B4
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Coxsackievirus B5
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Human mastadenovirus F
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Coxsackievirus B6
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Human mastadenovirus E
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Coxsackievirus B1
Lung-Ciliated cells : 86.56% ;
Lung-ATI : 67.20% ;
Lung-Secretory cells : 65.85% ;
Lung-Fibroblasts : 55.28% ;
Lung-ATII : 50.57% ;
Lung-Ciliated cells : 85.31% ;
Lung-ATII : 80.66% ;
Lung-Secretory cells : 77.00% ;
Lung-ATI : 69.60% ;
Lung-Fibroblasts : 46.34% ;
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
Enterovirus B
PBMC-Macrophage : 85.94% ;
PBMC-B cells : 32.19% ;
PBMC-Monocytes : 29.56% ;
PBMC-DCs : 23.54% ;
Coxsackievirus A9
Lung-Ciliated cells : 85.31% ;
Lung-ATII : 80.66% ;
Lung-Secretory cells : 77.00% ;
Lung-ATI : 69.60% ;
Lung-Fibroblasts : 46.34% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Human alphaherpesvirus 1
Lung-Ciliated cells : 85.31% ;
Lung-ATII : 80.66% ;
Lung-Secretory cells : 77.00% ;
Lung-ATI : 69.60% ;
Lung-Fibroblasts : 46.34% ;
Lung-Ciliated cells : 81.89% ;
Lung-Fibroblasts : 62.60% ;
Lung-Secretory cells : 41.12% ;
Lung-ATII : 33.37% ;
Lung-ATI : 23.60% ;
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
Lung-ATII : 47.29% ;
Lung-Ciliated cells : 38.15% ;
Lung-Secretory cells : 34.49% ;
Lung-Endothelial cells : 28.26% ;
PBMC-Macrophage : 31.25% ;
Lung-Secretory cells : 27.53% ;
Amphotropic murine leukemia virus
Lung-Ciliated cells : 83.71% ;
Lung-Fibroblasts : 54.47% ;
Lung-Secretory cells : 52.61% ;
Lung-ATII : 38.01% ;
Lung-ATI : 35.40% ;
Feline leukemia virus strain B/lambda-B1
Lung-Ciliated cells : 83.71% ;
Lung-Fibroblasts : 54.47% ;
Lung-Secretory cells : 52.61% ;
Lung-ATII : 38.01% ;
Lung-ATI : 35.40% ;
PBMC-Macrophage : 81.25% ;
PBMC-B cells : 62.33% ;
PBMC-NK cells : 57.21% ;
PBMC-Monocytes : 51.10% ;
Lung-Ciliated cells : 34.05% ;
Gibbon ape leukemia virus
Lung-Ciliated cells : 83.71% ;
Lung-Fibroblasts : 54.47% ;
Lung-Secretory cells : 52.61% ;
Lung-ATII : 38.01% ;
Lung-ATI : 35.40% ;
PBMC-Macrophage : 81.25% ;
PBMC-B cells : 62.33% ;
PBMC-NK cells : 57.21% ;
PBMC-Monocytes : 51.10% ;
Lung-Ciliated cells : 34.05% ;
Feline calicivirus
Lung-Ciliated cells : 82.80% ;
Lung-Fibroblasts : 69.51% ;
Lung-Secretory cells : 62.37% ;
Lung-ATII : 46.04% ;
Lung-Endothelial cells : 36.96% ;
Simian sarcoma-associated virus
PBMC-Macrophage : 81.25% ;
PBMC-B cells : 62.33% ;
PBMC-NK cells : 57.21% ;
PBMC-Monocytes : 51.10% ;
Lung-Ciliated cells : 34.05% ;
Xenotropic murine leukemia virus
Lung-Ciliated cells : 76.42% ;
Lung-ATII : 74.66% ;
Lung-Fibroblasts : 62.20% ;
Lung-Secretory cells : 56.45% ;
Lung-Macrophages : 52.94% ;
Polytropic murine leukemia virus
Lung-Ciliated cells : 76.42% ;
Lung-ATII : 74.66% ;
Lung-Fibroblasts : 62.20% ;
Lung-Secretory cells : 56.45% ;
Lung-Macrophages : 52.94% ;
Severe acute respiratory syndrome coronavirus 2
Lung-Fibroblasts : 70.33% ;
Lung-ATI : 53.20% ;
Lung-Secretory cells : 51.22% ;
Lung-ATII : 48.87% ;
Lung-Endothelial cells : 43.48% ;
Lung-Secretory cells : 36.59% ;
Lung-Ciliated cells : 35.19% ;
Lung-Fibroblasts : 30.89% ;
Lung-Endothelial cells : 29.35% ;
Ebola virus
Lung-Ciliated cells : 70.16% ;
Lung-ATII : 50.00% ;
Lung-Secretory cells : 44.95% ;
Lung-ATI : 37.00% ;
Lung-Endothelial cells : 29.35% ;
PBMC-Macrophage : 54.69% ;
PBMC-DCs : 22.52% ;
Lung-Fibroblasts : 22.36% ;
Echovirus E21
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E33
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E11
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E7
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E20
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E6
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Coxsackievirus A21
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Lung-Endothelial cells : 42.39% ;
Lung-Secretory cells : 31.36% ;
Lung-Fibroblasts : 29.67% ;
Lung-ATII : 28.96% ;
Lung-Ciliated cells : 25.51% ;
Echovirus E29
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E12
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Human enterovirus 70
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Echovirus E13
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Enterovirus D68
Lung-Ciliated cells : 66.86% ;
Lung-Fibroblasts : 57.32% ;
Lung-Macrophages : 50.98% ;
Lung-Secretory cells : 37.98% ;
Lung-ATI : 33.20% ;
Latino mammarenavirus
Lung-Ciliated cells : 66.40% ;
Lung-Fibroblasts : 50.41% ;
Lung-Secretory cells : 44.25% ;
Lung-ATI : 41.00% ;
Lung-ATII : 31.33% ;
Lymphocytic choriomeningitis mammarenavirus
Lung-Ciliated cells : 66.40% ;
Lung-Fibroblasts : 50.41% ;
Lung-Secretory cells : 44.25% ;
Lung-ATI : 41.00% ;
Lung-ATII : 31.33% ;
Lassa mammarenavirus
Lung-Ciliated cells : 66.40% ;
Lung-Fibroblasts : 50.41% ;
Lung-Secretory cells : 44.25% ;
Lung-ATI : 41.00% ;
Lung-ATII : 31.33% ;
PBMC-Macrophage : 54.69% ;
PBMC-DCs : 22.52% ;
Lung-Ciliated cells : 40.77% ;
Lung-Fibroblasts : 38.62% ;
Lung-Secretory cells : 32.75% ;
PBMC-DCs : 26.34% ;
Lung-ATII : 23.64% ;
Oliveros mammarenavirus
Lung-Ciliated cells : 66.40% ;
Lung-Fibroblasts : 50.41% ;
Lung-Secretory cells : 44.25% ;
Lung-ATI : 41.00% ;
Lung-ATII : 31.33% ;
Hepacivirus C
Lung-Ciliated cells : 66.29% ;
Lung-ATI : 63.00% ;
Lung-Secretory cells : 54.36% ;
Lung-ATII : 46.04% ;
Lung-Endothelial cells : 34.78% ;
Lung-Secretory cells : 63.07% ;
Lung-Ciliated cells : 40.20% ;
Lung-Fibroblasts : 35.37% ;
Lung-ATII : 29.64% ;
Lung-Ciliated cells : 52.85% ;
Lung-Secretory cells : 47.74% ;
Lung-ATII : 46.27% ;
Lung-ATI : 26.80% ;
Lung-Fibroblasts : 21.54% ;
Lung-Fibroblasts : 51.22% ;
Lung-Ciliated cells : 50.57% ;
PBMC-Macrophage : 37.50% ;
Lung-Secretory cells : 34.15% ;
PBMC-DCs : 21.75% ;
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Lung-Secretory cells : 36.59% ;
Lung-Ciliated cells : 35.19% ;
Lung-Fibroblasts : 30.89% ;
Lung-Endothelial cells : 29.35% ;
Lung-Ciliated cells : 27.68% ;
Lung-Secretory cells : 25.78% ;
Lung-Macrophages : 23.53% ;
Simian immunodeficiency virus
PBMC-Macrophage : 64.06% ;
PBMC-T cells : 51.45% ;
Human immunodeficiency virus 1
PBMC-Macrophage : 64.06% ;
PBMC-T cells : 51.45% ;
PBMC-Macrophage : 32.81% ;
PBMC-Monocytes : 30.94% ;
PBMC-B cells : 30.82% ;
PBMC-DCs : 25.98% ;
Human papillomavirus type 16
Lung-Secretory cells : 58.88% ;
Lung-Ciliated cells : 42.03% ;
Lung-ATII : 39.59% ;
PBMC-Platelets : 39.25% ;
Lung-Endothelial cells : 31.52% ;
Lung-Fibroblasts : 43.09% ;
PBMC-Platelets : 42.99% ;
Lung-Ciliated cells : 34.85% ;
PBMC-Macrophage : 28.12% ;
Lung-Secretory cells : 25.44% ;
Murine hepatitis virus
Lung-Ciliated cells : 58.43% ;
Lung-Secretory cells : 57.84% ;
Lung-ATII : 27.15% ;
Lung-Endothelial cells : 22.83% ;
Lung-Fibroblasts : 21.14% ;
Canine coronavirus
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Porcine epidemic diarrhea virus
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Human coronavirus 229E
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Transmissible gastroenteritis virus
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Feline coronavirus
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Infectious bronchitis virus
PBMC-DCs : 56.44% ;
PBMC-Macrophage : 48.44% ;
Lung-ATII : 43.33% ;
Lung-Ciliated cells : 28.70% ;
Lung-Fibroblasts : 21.54% ;
Hepatovirus A
PBMC-Macrophage : 54.69% ;
PBMC-DCs : 22.52% ;
Marburg marburgvirus
PBMC-Macrophage : 54.69% ;
PBMC-DCs : 22.52% ;
Lung-Fibroblasts : 22.36% ;
West Nile virus
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Human parechovirus 1
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Human gammaherpesvirus 8
Lung-Fibroblasts : 54.47% ;
Lung-Ciliated cells : 51.94% ;
Lung-Secretory cells : 51.57% ;
Lung-ATII : 50.23% ;
Lung-ATI : 36.40% ;
PBMC-Platelets : 21.96% ;
Lung-Fibroblasts : 21.14% ;
Human rhinovirus A2
Lung-Ciliated cells : 52.85% ;
Lung-Secretory cells : 47.74% ;
Lung-ATII : 46.27% ;
Lung-ATI : 26.80% ;
Lung-Fibroblasts : 21.54% ;
Human alphaherpesvirus 3
Lung-Secretory cells : 52.26% ;
Lung-Ciliated cells : 49.54% ;
Lung-Fibroblasts : 41.06% ;
Lung-ATI : 29.00% ;
Lung-ATII : 28.96% ;
Varicella Zoster Virus
Lung-Secretory cells : 52.26% ;
Lung-Ciliated cells : 49.54% ;
Lung-Fibroblasts : 41.06% ;
Lung-ATI : 29.00% ;
Lung-ATII : 28.96% ;
Human immunodeficiency virus 2
PBMC-T cells : 51.45% ;
PBMC-Macrophage : 32.81% ;
PBMC-Monocytes : 30.94% ;
PBMC-B cells : 30.82% ;
PBMC-DCs : 25.98% ;
Human betaherpesvirus 7
PBMC-T cells : 51.45% ;
Hepatitis E virus
Lung-Ciliated cells : 49.77% ;
Lung-Fibroblasts : 43.09% ;
Lung-Secretory cells : 42.16% ;
Lung-ATI : 37.60% ;
Lung-ATII : 37.33% ;
Middle East respiratory syndrome-related coronavirus
Lung-Fibroblasts : 48.78% ;
Lung-Secretory cells : 39.72% ;
Bovine leukemia virus
PBMC-Macrophage : 48.44% ;
Lung-Ciliated cells : 40.77% ;
Lung-ATII : 32.24% ;
Lung-Secretory cells : 31.71% ;
PBMC-B cells : 27.17% ;
Human alphaherpesvirus 2
Lung-ATII : 47.29% ;
Lung-Ciliated cells : 38.15% ;
Lung-Secretory cells : 34.49% ;
Lung-Endothelial cells : 28.26% ;
PBMC-Macrophage : 31.25% ;
Lung-Secretory cells : 27.53% ;
Suid alphaherpesvirus 1
Lung-ATII : 47.29% ;
Lung-Ciliated cells : 38.15% ;
Lung-Secretory cells : 34.49% ;
Lung-Endothelial cells : 28.26% ;
PBMC-Macrophage : 31.25% ;
Lung-Secretory cells : 27.53% ;
Coxsackievirus A10
Lung-Ciliated cells : 44.76% ;
Lung-Fibroblasts : 34.55% ;
Porcine reproductive and respiratory syndrome virus
Lung-Fibroblasts : 43.09% ;
PBMC-Platelets : 42.99% ;
Lung-Ciliated cells : 34.85% ;
PBMC-Macrophage : 28.12% ;
Lung-Secretory cells : 25.44% ;
Rhinovirus B14
Lung-Endothelial cells : 42.39% ;
Lung-Secretory cells : 31.36% ;
Lung-Fibroblasts : 29.67% ;
Lung-ATII : 28.96% ;
Lung-Ciliated cells : 25.51% ;
Hendra henipavirus
Lung-Endothelial cells : 41.30% ;
PBMC-Macrophage : 26.56% ;
PBMC-Platelets : 21.96% ;
PBMC-B cells : 21.92% ;
Nipah henipavirus
Lung-Endothelial cells : 41.30% ;
PBMC-Macrophage : 26.56% ;
PBMC-Platelets : 21.96% ;
PBMC-B cells : 21.92% ;
Mouse mammary tumor virus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Machupo mammarenavirus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Feline panleukopenia virus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Argentinian mammarenavirus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Guanarito mammarenavirus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Canine parvovirus
Lung-Ciliated cells : 40.77% ;
Lung-Secretory cells : 30.31% ;
Lung-ATII : 28.73% ;
Ecotropic murine leukemia virus
Lung-Secretory cells : 35.19% ;
Lung-Ciliated cells : 27.45% ;
Encephalomyocarditis virus
Lung-Endothelial cells : 34.78% ;
Murine norovirus
Lung-Macrophages : 33.33% ;
Feline immunodeficiency virus
PBMC-Macrophage : 32.81% ;
PBMC-Monocytes : 30.94% ;
PBMC-B cells : 30.82% ;
PBMC-DCs : 25.98% ;
Bovine alphaherpesvirus 1
PBMC-Macrophage : 31.25% ;
Lung-Secretory cells : 27.53% ;
Respiratory syncytial virus
PBMC-NK cells : 24.85% ;
PBMC-DCs : 24.30% ;
Hantaan orthohantavirus
PBMC-Platelets : 21.96% ;
Feline leukemia virus strain C/FA27
Lung-Secretory cells : 21.25% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China